Previous close | 20.35 |
Open | 20.71 |
Bid | 0.00 x 3000 |
Ask | 0.00 x 3100 |
Day's range | 20.62 - 20.99 |
52-week range | 14.91 - 22.18 |
Volume | |
Avg. volume | 7,077,038 |
Market cap | 39.986B |
Beta (5Y monthly) | 2.85 |
PE ratio (TTM) | 14.27 |
EPS (TTM) | 1.47 |
Earnings date | N/A |
Forward dividend & yield | 0.41 (2.03%) |
Ex-dividend date | 14 Sept 2023 |
1y target est | 22.37 |
Cenovus (CVE) continues to reduce debt through free fund flow generation and asset divestments.
Higher contributions from the Canadian Manufacturing unit and lower expenses aid Cenovus' (CVE) earnings in Q2.
Cenovus (CVE) delivered earnings and revenue surprises of 3.13% and 6.05%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?